BioCentury
ARTICLE | Clinical News

NPC-1C ELISA diagnostic data

January 24, 2011 8:00 AM UTC

An analysis of serum samples from 41 patients with colorectal or pancreatic cancer and 28 healthy controls showed that Neogenix's NPC-1C ELISA had 82% sensitivity and 71% specificity for detecting can...